Prepro-thyrotropin-releasing hormone 178-199 exerts partial protection against cerebral ischemia in adult rats

NeuroReport

Volumn 10, Issue 17, 1999, Pages 3501-3505

  Borlongan, Cesario V ^a   Stahl, Christine E ^b   Redei, Eva ^c   Wang, Yun ^a,d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b WILLIAM BEAUMONT ARMY MEDICAL CENTER   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Corticosterone; Corticotrophin release inhibiting factor; Infarction; Locomotor activity; Stress; Stroke

Indexed keywords

CORTICOSTERONE; HORMONE PRECURSOR; PREPRO THYROTROPIN RELEASING HORMONE 178-199; PROTIRELIN DERIVATIVE; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DRUG EFFECT; FRONTAL CORTEX; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS; STROKE;

EID: 0033607431     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199911260-00007     Document Type: Article

References (27)

1. 1. de Wied D and de Kloet ER. Ann NY Acad Sci 512, 328-337 (1987).
2. 2. Kalin NH, Takahashi LK and Chen FL. Brain Res 656, 182-186 (1994).
3. 3. Redei E, Rittenhouse PA, Revskoy S et al. Ann N Y Acad Sci 840, 456-469 (1998).
4. 4. Redei E, Hilderbrand H and Aird F. Endocrinology 136, 1813-1816 (1995).
5. 5. Redei E, Hilderbrand H and Aird F. Endocrinology 136, 3557-3563 (1995).
6. 6. McGivern RF, Rittenhouse P, Aird F et al. J Neurosci 17, 4886-4894 (1997).
7. 7. Kadar T, Dachir S, Shukitt-Hale B et al. J Neural Transm 105, 987-1004 (1998).
8. 8. Antonawich FJ, Miller G, Rigsby DC et al. Neuroscience 88, 319-325 (1999).
9. 9. McEwen BS and Magarinos AM. Ann NY Acad Sci 821, 271-284 (1997).
10. 10. Koplik EV, Gannushkina IV, Antelava AL et al. Fiziol Zh Im I M Sechenova 9, 35-39 (1995).
11. 11. Thoresen M, Bagenholm R, Loberg EM et al. Neuroreport 7, 481-484 (1996).
12. 12. Sembi S, Tarrier N, O'Neill P et al. Int J Geriatr Psychiatry 13, 315-322 (1998).
13. 13. Murros K, Fogelholm R, Kettunen S et al. J Neurol Sci 116, 12-17 (1993).
14. 14. Marta-Moreno J, Mostacero E, Lopez del Val J et al. Rev Neurol 25, 535-540 (1997).
15. 15. Lyons MK, Anderson RE and Meyer FB. Brain Res 545, 339-342 (1991).
16. 16. Strijbos PJ, Relton JK and Rothwell NJ. Brain Res 656, 405-408 (1994).
17. 17. Koizumi J, Yoshida Y, Nakazawa T and Ooneda G. Jpn J Stroke 8, 1-8 (1986).
18. 18. Nishino H, Koide K, Aihara N et al. Brain Res Bull 32, 517-520 (1993).
19. 19. Chen ST, Hsu CY, Hogan EL et al. Stroke 17, 738-743 (1986).
20. 20. Du C, Hu R, Csernansky CA et al. J Cerebr Blood Flow Metab 16, 195-201 (1996).
21. 21. Borlongan CV and Sanberg PR. J Neurosci 15, 5372-5378 (1995).
22. 22. Borlongan CV, Hida H and Nishino H. Neuroreport 9, 3615-3621 (1998).
23. 23. Wang Y, Lin SZ, Chiou AL et al. J Neurosci 17, 4341-4348 (1997).
24. 24. Fitch RH, McGivern RF, Redei E et al. Acta Endocrinol 126, 44-48 (1992).
25. 25. Abel GA, Chen X, Boden-Albala B et al. Neuroepidemiology 18, 22-31 (1999).
26. 26. Kadojic D, Demarin V, Kadojic M et al. Coll Antropol 23, 213-219 (1999).
27. 27. Inzitari D, Pantoni L, Lamassa M et al. Arch Neurol 54, 866-873 (1997).